Literature DB >> 2161300

The loss of circadian rhythm for intact parathyroid hormone and nephrogenous cyclic AMP in patients with primary hyperparathyroidism.

F C Logue1, W D Fraser, S J Gallacher, D A Cameron, D S O'Reilly, G H Beastall, U Patel, I T Boyle.   

Abstract

The measurement of serum intact parathyroid hormone (PTH) (1-84) over a 24-h period has shown the existence of a circadian rhythm in normal males which is absent in patients with primary hyperparathyroidism. The physiological significance of this observation is reflected in the presence of parallel changes in nephrogenous cyclic adenosine monophosphate (N-cAMP) in normals which are also absent in primary hyperparathyroidism. Serum calcium, adjusted for variations in albumin concentrations, showed a transient fall in normal subjects prior to the nocturnal rise in PTH (1-84). A similar transient fall in serum adjusted calcium was observed in the hyperparathyroid patients. Serum phosphate showed a circadian rhythm in normal subjects, and an attenuated rhythm persisted in primary hyperparathyroidism. These data suggest that both ionic factors and higher centres play important roles in the fine control of PTH (1-84) secretion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161300     DOI: 10.1111/j.1365-2265.1990.tb00888.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  ACP Broadsheet no 144: July 1994. The investigation of hypercalcaemia. Association of Clinical Pathologists.

Authors:  P L Selby; P H Adams
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

2.  The circadian rhythm of calcium and bone homeostasis in Maasai.

Authors:  Anne Schou; Niklas Rye Jørgensen; Venance Phillip Maro; Kajiru Kilonzo; Kaushik Ramaiya; Joseph Sironga; Andreas Kryger Jensen; Dirk Lund Christensen; Peter Schwarz
Journal:  Am J Hum Biol       Date:  2022-04-28       Impact factor: 2.947

3.  Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis.

Authors:  W D Fraser; F C Logue; J P Christie; S J Gallacher; D Cameron; D S O'Reilly; G H Beastall; I T Boyle
Journal:  Osteoporos Int       Date:  1998       Impact factor: 5.071

4.  Development of experimental chronic kidney disease and vascular calcification alters diurnal variation of phosphate and its hormonal regulators.

Authors:  Bruno A Svajger; Justin L H Riddoch; Cynthia M Pruss; Kimberly J Laverty; Emilie Ward; Rachel M Holden; Michael A Adams
Journal:  Physiol Rep       Date:  2020-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.